Restraints & Challenges:
Global Genomic Biomarker Market – Restraints
However, certain drawbacks associated with the utility and analysis of genomic biomarkers is expected to hamper the growth of its market over the forecast period. For instance, according to an article published by the Intestinal Journal in November 2019, some genomic biomarkers such as miRNA present in stool sample cannot be used as a standalone diagnostic tool for the detection of colon cancer, due to concerns regarding stability of biomarker and failure to establish adequate predictive value for the diagnosis of colon cancer.
Genomic Biomarker Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients